Home > News > Pharmaceutical News

Pharmaceutical News

Read latest Pharmaceutical News when a major Pharmaceutical scoop arises.

Cipla arm to exit China's Jiangsu

Mumbai, Dec 10 : Pharma major Cipla's Mauritius-based subsidiary Meditab Holding Ltd is selling its entire equity stake of 48.22 percent, valued at $18.5 million (Rs.115 crore), in Jiangsu Cdymax Pharmaceuticals Co Ltd in China.

Fair trade regulator clears merger between Sun Pharma, Ranbaxy

New Delhi, Dec 8 : Indian fair trade regulator Competition Commission of India (CCI) Monday cleared the $4 billion merger between pharmaceutical majors Sun Pharma and Ranbaxy, with the condition that both the companies would have to divest seven key products.

GVK Bio offers to re-do studies after EU ruling

Hyderabad, Dec 8 : Pharmaceutical research company GVK Biosciences has offered to re-do studies at its own cost after the European Union suspended marketing approval of some generic drugs due to alleged manipulation of data related to clinical trials.

Pharmaceutical products pollute Antarctic waters: Study

Sydney, Dec 4 : A research team from New Zealand Thursday warned of the threat posed by pharmaceutical products, as also soaps and cosmetics, dumped in the Antarctic waters by Antarctic research bases.

Lupin gets USFDA nod for anti-arthritis medicine

New Delhi, Nov 3 : Pharmaceutical major Lupin Monday said that it has received final approvals for its anti-arthritis medicine Celecoxib Capsules by the US Food and Drugs Administration (FDA).

Eli Lilly transfers TB drug tech to Shasun chemicals

New Delhi, Nov 1 : Global healthcare company Eli Lilly and Company completed the technology transfer of multi-drug resistant tuberculosis (MDR-TB) drug Cycloserine in India to Shasun Chemicals and Drugs Ltd. Chennai, the company said here.

Avigan Tablet 200mg administered to a French woman infected with Ebola virus

Tokyo, Oct. 31 : Fujifilm Corporation announced that the anti-influenza drug Avigan Tablet 200mg' *(Favipiravir), developed by the Fujifilm Group company Toyama Chemical Co., Ltd, has been administered to a patient infected with the Ebola virus disease at a hospital in France.

Ebola vaccine in five years: Israeli scientist

Jerusalem, Oct 30 : Leslie Lobel, a virologist at Israel's Ben-Gurion University, is not surprised by the current epidemic of the Ebola virus disease in West Africa and says that sooner or later it would have happened.

Dr Reddy's Q2 net down by 17 percent

Hyderabad, Oct 29 : Pharmaceutical major Dr Reddy's Laboratories Limited has reported 17 percent decline in net profit during the second quarter ended September, at Rs.574.10 crore against Rs.690.25 crore in the corresponding quarter last year.

Ranbaxy to pay USD 40 mn to settle Texas litigation

New Delhi, Oct 16 : Drugmaker Ranbaxy Laboratories Thursday said it has settled the litigation concerning its participation in the Texas Medicaid Program and agreed to pay USD 39.75 million.

Indian pharmacy through an eminent pioneer's eyes

By Ashok Dixit, New Delhi, Oct. 15 : Eminent academic, medicinal chemist and pharmaceutical historian Professor Harkishan Singh's autobiography "Witness to an Era" traces an over six-decade-long journey from a forgotten India of the 1940s, when a majority of people in its northern parts overcame the mayhem of partition to emerge as success stories, to a 21st century information technology-driven nation to be proud of.

Abbott opens new manufacturing plant

New Delhi, Oct 15 : Health-care major Abbott Wednesday opened its new greenfield nutrition manufacturing plant in Jhagadia, Gujarat, which has come up with an investment of Rs.450 crore (USD 75 million).

Regulator's power to cap non-essential drugs' prices withdrawn

New Delhi, Sep 23 : The government has withdrawn the regulator, National Pharmaceutical Pricing Authority's (NPPA) powers of fixing the prices of non-essential medicines.

Sun Pharma to acquire rights for Merck's dermatology drug

Chennai, Sep 17 : In an USD 80 million deal, India's pharmaceutical major Sun Pharmaceutical Industries Ltd. will acquire worldwide rights to US-based Merck and Co Inc's tildrakizumab, an investigational therapeutic antibody candidate, the company said.

Johnson and Johnson's biggest plant coming up in Telangana

Hyderabad, Sep 16 : Global pharmaceuticals and consumer packaged goods manufacturer Johnson and Johnson's biggest manufacturing facility in India is set to come up in Telangana with an investment of Rs.400 crore.

Lupin ties up with Merck Serono for expansion in emerging markets

Mumbai, Sep 16 : Pharma major Lupin Tuesday entered into a long-term strategic partnership with Germany-based biopharmaceutical firm Merck Serono for expansion of its portfolio initiative in emerging markets.

Competition watchdog seeks public comments on Sun-Ranbaxy deal

New Delhi, Sep 4 : The Competition Commission of India (CCI) Thursday invited comments from all stakeholders, including the general public, on the merger of pharma companies Ranbaxy Laboratories and Sun Pharmaceutical Industries, signalling the first public scrutiny of a merger and acquisition (M and A) agreement in the country.

Indian-origin scientist finds way to develop better drugs

New York, Aug 26 : An Indian-origin researcher at Michigan Technological University has deciphered how Glycoconjugates - biomolecules that hold sugars in the body like scaffolds for reacting with other molecules - can lead to new and better drugs.

WHO approves use of unproven Ebola drugs

Washington, Aug 13 : Ebola drugs that are currently being used to treat some patients in the West Africa are ethically sound, say the World Health Organization officials.

Rotavirus vaccine can reduce 26,985 deaths in India: Report

Kolkata, Aug 12 : The central government's decision to introduce rotavirus vaccine in India's Universal Immunization Programme can reduce as many as 26,985 deaths annually due to rotaviral diarrhoea, a study said.

Mass production of Ebola drug may take months

Washington, Aug 7 : Mass production of an experimental drug given to two US aid workers with Ebola may take "several months", the US manufacturer said Wednesday.

Lupin to market diabetic drug with Korean company

Chennai, Aug 6 : Drug major Lupin Ltd Wednesday announced its agreement with South Korean company LG Life Sciences to source and market in India diabetic medicine Insulin Glargine under the brand Basugine.

Cura Healthcare buys diagnostic imaging company

Chennai, July 31 : City-based medical technology company Cura Healthcare has turned acquisitive to enter the ultrasound equipment segment by buying diagnostic imaging company DE Healthcare, said a top company official.

Is paracetamol a back ache drug or just placebo?

Washington, July 24 : A new study has revealed paracetamol is no better than Placebo as it does not help in speedy recovery from severe lower back pain or improving pain levels, function, sleep, or quality of life.

Misuse of pharmaceutical drugs rising in India: UN official

By Rajnish Singh, New Delhi, July 24 : After cannabis and heroin, the misuse of pharmaceutical drugs is rising among subcontinental drug users because of their easy availability at cheap rates and this is a cause for concern, a top UN official has said.

HLL Life Care shies from sexual wellness products

Thiruvananthapuram, July 18 : Scientists at HLL Life Care here are not entering the multi-billion dollar business of sexual wellness products as they work on the next generation of male contraceptive, a senior official said Friday.

Indian pharma firms face competition from Pakistan in Nigeria

By Francis Kokutse, Accra, July 13 : As Indian pharmaceutical companies prepare to increase the volume of their trade in Nigeria, it is becoming clear that they would have to compete companies from their closest neighbour, Pakistan, which have given the signal that they are keen to take a slice of Nigeria's growing market in the health sector as well as pharmaceutical products.

Cura Healthcare acquires Concept Integrations

Chennai, July 3 : City-based medical technology company Cura Healthcare is looking at developing countries for its products, said a top company official.

BITS Pilani-Hyderabad develops antibiotic finder

Hyderabad, July 1 : BITS Pilani-Hyderabad has developed a new low-cost, ultra-rapid portable device to test antibiotic sensitivity of human urinary pathogens which can help curb antibiotic resistance to a large extent.

Kiran Mazumdar-Shaw awarded Kiel Institute's 2014 Global Economy Prize

Bangalore, June 23 : Kiran Mazumdar-Shaw, Chairperson and Managing Director of Biocon Ltd, Asia's leading bio-pharmaceutical company, has been awarded the Kiel Institute's most coveted '2014 Global Economy Prize' for business during the 100th anniversary celebrations of the Institute held in Kiel, Germany on Sunday, June 22.

Hilleman Labs, Gotovax AB to develop cholera vaccine

New Delhi, June 17 : Two global pharmaceutical firms - Hilleman Laboratories and Gotovax AB - Tuesday joined hands to develop affordable oral cholera vaccine.

USD 147-million IFC loan to Jubilant Pharma

Bangalore, May 26 : The International Finance Corporation (IFC) of the World Bank is lending USD 147.5 million (Rs.863 crore) to Jubilant Pharma, a Singapore-based subsidiary of drug major Jubilant Life Sciences, to ensure access to affordable drugs in underserved markets in India and other countries.

Ranbaxy-Sun Pharma deal: SC calls for ruling in two days

New Delhi, May 21 : The Supreme Court Wednesday asked the Andhra Pradesh High Court to decide in two days the issues that have been raised to stall the amalgamation of Ranbaxy Laboratories Limited with Sun Pharmaceutical Industries Limited following a USD 4 billion takeover deal.

HCG announces new diagnostics for cancer treatment in India

Kolkata, May 8 : HealthCare Global (HCG) Enterprises Ltd, the Specialists in Cancer Care on Thursday announced genomics-based diagnostics, a 'standard-of-care' for cancer treatment in India.

Caradigm joins Symphony Analytics to deliver healthcare solutions

Bangalore, May 7 : Healthcare analytics and population health company Caradigm recently signed a business cooperation agreement with analytic process integrator Symphony Analytics, to help healthcare providers rapidly improve clinical and financial outcomes through comprehensive healthcare analytics solutions. Under the agreement, Symphony Analytics will provide strategic consulting and implementation services to healthcare providers adopting the Caradigm Intelligence Platform and Caradigm analytics applications, including Caradigm Readmissions Management.

Shantha's Pentavalent Pediatric Vaccine prequalified by WHO

Hyderabad, May 5 : Sanofi Pasteur, the vaccines division of Sanofi on Monday announced that its pediatric pentavalent vaccine Shan5, developed and manufactured by its affiliate Shantha Biotechnics in Hyderabad, has received prequalification status from the World Health Organization (WHO).

Shantha's paediatric vaccine gets WHO prequalification

Hyderabad, May 5 : Shan5, a paediatric pentavalent or five-in-one vaccine developed by Hyderabad-based Shantha Biotechnics, an arm of Sanofi Pasteur, the vaccines division of French pharmaceutical company Sanofi, has regained prequalification status from the World Health Organisation (WHO).

India can be leader in supplying medicines: Cipla chairman

New Delhi, May 3 : India can be a global leader in supplying affordable and high quality medicines to the world, and especially to the underdeveloped countries where such medicines do not reach the poor because of their high cost and the monopoly of foreign manufacturers, said a leading entrepreneur.

US pharmaceutical giant Pfizer keen to acquire AstraZeneaca for USD 100 billion

Washington, Apr 21 : US based pharmaceutical company Pfizer has proposed to take over its British rival AstraZeneca for 60 billion pounds (101 billion dollars).

Nutraceuticals slams FSSAI 'Product Approval' scheme

Mumbai, Apr 14 : The importers and manufacturers of dietary supplements, health supplements, functional foods and nutraceutical industry have deplored the alleged ambiguous scheme of 'Product Approval' by the Food Safety and Standards Authority of India (FSSAI), despite having a stay order from the Bombay High Court for 6 months.

Some facts about drug over which Powell banned

London, April 11 : Oxilofrine, found in the dietary supplement of former world record holder in the 100 m Asafa Powell, is a stimulant drug banned by the World Anti-Doping Agency.

Sun Pharma to acquire Ranbaxy for USD four billion in all stock transaction

Mumbai, Apr. 7 : Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories Ltd has announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100 per cent of Ranbaxy in an all-stock transaction.

Sun Pharma to buy Ranbaxy for USD 4 billion in all-share deal

New Delhi, April 7 : India's largest drugmaker by market capitalisation Sun Pharma will buy out Japan's Daiichi-controlled Ranbaxy Laboratories for USD 4 billion in an all-share deal, the two companies said Monday.

Venus gets marketing nod from Venezuela for meropenem

Mumbai, Apr 3 : Venus Remedies Ltd, a research-based global pharmaceutical company, has extended its footprint in Latin America with marketing authorisation for meropenem from Venezuela, a USD 6-billion pharmaceutical market.

Jubilant Life to develop new drugs to combat TB

Bangalore, March 24 : Indian pharma major Jubilant Life Sciences Ltd's subsidiary Chemsys will develop new drugs in collaboration with a US-based research institute to combat tuberculosis in the Indian subcontinent.

Jubilant gets USD 3.4 mn for new anti-TB drugs

Bangalore, March 24 : Chemsys, a subsidiary of Indian pharma major Jubilant Life Sciences Ltd, has got an additional USD 3.4 million (Rs.21 crore) from a US-based research institute to develop new drugs for combating tuberculosis (TB) in the sub-continent, it was announced Monday.

Prolonged crisis in Ukraine could affect Indian pharma companies

New Delhi, Mar.18 : While recent developments in Ukraine have had no immediate impact on the businesses of leading Indian pharmaceutical companies based in Ukraine, it is felt that if the situation continues then it could have a bearing on the country's exchange rate that would make the landed cost of Indian pharmaceuticals higher.

Strand receives US patent for virtual liver

Bangalore, Mar 13 : Strand Life Sciences (Strand), a Bangalore and San Francisco-based bioinformatics and systems biology company has received patent protection for its "method for predicting organ toxicity and a system thereof" in the United States (USPTO patent no. 8,645,075) effective from Feb 4.

India pledges new low-cost drugs to developing nations

New Delhi, March 10 : Stressing that India's pharmaceutical technology was appropriate for Africa, Commerce Minister Anand Sharma said India is committed to making available to developing countries newer generation life-saving drugs also.

Lupin gets FDA nod for Mycobutin generic version

New Delhi, Feb 26 : Drug maker Lupin Wednesday said it has received final approval from the US health regulator to market the generic version of Mycobutin capsules of Pharmacia and Upjohn Company used in treating advance HIV infection.

Ranbaxy stops API production at two plants

New Delhi, Feb 25 : India's largest drug maker Ranbaxy Laboratories Tuesday said it has halted temporarily drug ingredient production at two of its facilities in the country as a "precautionary measure".

Ranbaxy to settle with New York attorney general

New York, Feb 19 : India's Ranbaxy Laboratories and Israel's Teva pharmaceutical Industries are set to settle over allegations that the two rival generic drug makers made an unlawful agreement to restrict competition, according to a media report.

GSK Pharma's Rs.6,400 crore open offer begins Tuesday

Mumbai, Feb 16 : The Britain-based GlaxoSmithKline Plc's voluntary open offer to the shareholders of its Indian subsidiary GlaxoSmithKline Pharmaceuticals (GSK Pharma) is scheduled to start Tuesday.

Cipla head donates Rs.8 crore to promote chemistry in India

Bangalore, Feb 10 : Pharma major Cipla chairman Yusuf Hamied Monday donated Rs.8 crore to support a chemistry education programme in Indian schools by the Britain-based Royal Society of Chemistry.

Ranbaxy registers sales of Rs.28.6 billion in fourth quarter

Gurgaon/ Tokyo,Feb.5 : The Board of Directors of Ranbaxy Laboratories Limited at its meeting held today, took on record the unaudited results for the Quarter and YTD ended December 31, 2013 under Indian GAAP.

AstraZeneca to shut R and D centre in Bangalore

Bangalore, Jan 29 : British pharma major AstraZeneca plc Wednesday announced the closing of its research and development (R and D) centre here but said it will continue manufacturing and marketing operations in India.

US FDA bans more products from Ranbaxy

By Arun Kumar, Washington, Jan 24 : In another setback to Ranbaxy, the US drug regulator has prohibited the Indian drugmaker from producing and distributing drugs for the US market from its Toansa facility in Punjab.

Jadavpur University hosts IAPST International Conference

Kolkata, Jan 17 : The Department of Pharmaceutical Technology, Jadavpur University along with the NSHM Knowledge Campus Group of Institutions and Indian Association of Pharmaceutical Scientists and Technologists (IAPST) on Friday hosted the 2nd Pharma Tech IAPST International Conference, here.

Share this Page:

More News: